Several diseases are difficult to diagnose when there is a poor number of specific clinical markers or physical symptoms. This is the case of the actual Covid19 pandemic. According to the Pasteur Institute, 30 to 60% of infected people show an asymptomatic form of the disease, specifically for young people. To deal with virus transmission,…
Details
Since many years, Nirmidas and Innopsys work toogether to offer high tech solutions as Nirmidas Biotech pGOLDTM assay. It is an innovative microarray platform for viral infections screening and protein biomarkers analysis (Zika, Dengue and SARS-CoV-2, among others). Nirmidas’ technology use proprietary gold-coated slides based on nanotechnology. This technology gives superior sensitivity and precision for…
Details
Peptide arrays technology is an ideal tool to identify epitopes and develop synthetic vaccine. Vaccination, one of the main work of Jenner in the 18th century, aims to stimulate immune responses against pathogens and microbes. This is the most effective method for protecting individuals from infections. Persistent vaccination has eradicated some diseases as smallpox .…
Details
We are proud to anounce that our InnoScan 710-AL was notified to PMDA as a medical device. PMDA (Pharmaceuticals and Medical Devices Agency) is Japanese regulatory agency, working together with Ministry of Health, Labour and Welfare. Their obligation is to protect the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.…
Details
Innopsys is pleased to join the PartneringAgainstCovid19 Event. We are glad to share our expertise and help solving this pandemic. Since December 2019 the world is facing to a new virus, the SARS-CoV-2. The WHO has classified the Covid-19 pandemic as one of the worst public health problems. In order to fight viruses, microarrays have…
Details
#InnoScan scanners helping to virology research and anti-coronavirus vaccine development. #Coronavirus #peptideArrays #Covid19 #PEPperCHIP
Details